International Psoriasis Council

Advancing Knowledge. Improving Care.

Advancing Knowledge. Improving Care.

Shining a Spotlight on our 2022 Fellows: Get to Know the Future Leaders in Psoriasis – Albert Duvetorp, MD, PhD

Albert Duvetorp, MD, PhD

Skåne University Hospital

Skane, Sweden


Can you tell us briefly about your background and what led you to apply for this program?

I am a dermatologist residing in Malmö, Sweden. I currently have a post-doctorate position in Liv Eidsmo´s research group in Copenhagen being a fellow of the BRIDGE Translational Excellence Program funded by the Novo Nordisk Foundation. My childhood was primarily spent in Gran Canaria, in the Canary Islands, before relocating to Sweden at seventeen. My medical studies were completed in Gothenburg.

In 2021, I successfully earned my PhD, focusing my research on biomarkers for assessing psoriasis disease activity and exploring the relationship between psoriasis and comorbidity. As I neared the end of this extensive research journey and prepared for my doctoral defense, I reflected on what lay ahead. During this contemplative phase, I received an email from the IPC, introducing me to their Fellowship Program and the application process. Sometimes, life has a way of offering answers when we least expect it.

How has this program helped you grow personally and professionally?

The program has provided invaluable insights into physicians’ shared challenges when caring for patients with psoriasis globally. It has also offered me a unique perspective on the disparities in access to treatment, economic resources, and the organization of healthcare systems in various parts of the world.

Throughout this journey, I’ve had the pleasure of forging new friendships and have been deeply touched by the genuine kindness and warmth exhibited by the IPC Staff, Councilors, and other Fellows who are all part of this remarkable program.

“The program is a dynamic platform where individuals with shared interests exchange knowledge and engage. The program's thoughtful organization and friendly atmosphere naturally encourage collaboration and networking.” 

How has the program prepared you for your future career goals?

The program has significantly enriched and expanded my understanding of psoriasis as a medical condition. Perhaps even more valuable is the opportunity to connect with a network of colleagues who share a deep interest in this disease.

Can you share a specific project or accomplishment you're proud of from your time in the program?

My mentor, IPC Councilor Dr. Fernando Valenzuela, and I began a research initiative during my fellowship program. We engaged with psoriasis patients digitally, collecting their responses to multiple-choice questions about their perceptions of the disease. Our journey began in Chile and subsequently extended to Sweden. With the generous support of IPC Board Member Lone Skov, we successfully disseminated the questionnaire to individuals with psoriasis in Denmark. Juul van den Reek, an IPC Fellow from 2022, is currently preparing to assemble a cohort of Dutch participants for our study.

Establishing this multinational study has been a source of great satisfaction, particularly given the limited financial resources. It has also underscored the considerable potential of digitalizing research efforts. The prospects for investigator-initiated studies and cross-border collaborations appear exceedingly promising.

How has the program fostered collaboration and networking among IPC Board, Councilors, and Fellows?

The program is a dynamic platform where individuals with shared interests exchange knowledge and engage. The program’s thoughtful organization and friendly atmosphere naturally encourage collaboration and networking. These interactions occur virtually and in person, including at events during congresses or the annual IPC Think Tank Meeting.

Can you describe the mentorship and support you've received from the program faculty, IPC staff, and other IPC Fellows?

As mentioned previously, the IPC Fellowship Program exudes a welcoming and supportive environment. This spirit of camaraderie naturally extends to offering assistance across a spectrum of needs, whether addressing logistical concerns or providing guidance when tackling complex clinical questions.

What advice would you give to someone considering applying for this program?
In what ways do you think this program is unique and sets itself apart from other programs?

The IPC Fellowship Program embodies a remarkable level of ambition, and it’s evident that the IPC has excelled in enlisting the expertise of top global psoriasis specialists as educators and mentors. What truly sets this program apart is its global perspective, a feature that I find quite extraordinary. Fellow participants hail from various corners of the world, creating a fascinating mosaic of viewpoints and backgrounds. Our digital meetings genuinely intrigued me, where participants, spanning many time zones, came together, revealing a diverse blend of seasons – some experiencing the depths of winter. In contrast, others reveled in the warmth of summer.

If you are a young dermatologist or researcher that is passionate about improving the lives of people with psoriasis and wants to expand your horizons, consider applying to participate in the IPC’s International Fellowship Program. Applications for the 2024 program is open through the end of September.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.


Recent Posts

New IPC Guidelines on Generalized Pustular Psoriasis

Commentary: An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis

Introducing our Latest IPC Councilors: Experts in Psoriasis Treatment and Research

Also Read

Generalized Pustular Psoriasis

New IPC Guidelines on Generalized Pustular Psoriasis

Learn about the new global diagnostic criteria for Generalized Pustular Psoriasis as set by the International Psoriasis Council. Discover the essential features, the importance of accurate diagnosis, and the expected global impact on patient care.

Read More

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.